PNNL highlights four researchers whose joint appointments are creating new and diverse opportunities for expanding knowledge and scientific impact across institutions.

PNNL biomedical scientist Josh Adkins brings expertise analyzing biomolecules in dynamic systems.

Genetic and integrated multi-omic details of glioblastoma could one day inform new therapies.

The Metabolomics Association of North America promotes the field’s development across the continent.

Researchers propose and test foundational concepts for the new subdiscipline of “meta-metabolome ecology.”

The Marine and Coastal Research Laboratory (MCRL), part of PNNL, in Sequim, Washington, is the U.S. Department of Energy’s only marine research facility. It has a rich history and expanding research scope.

PNNL researchers are looking for protein signatures that could provide information about how the body's immune system responds to COVID-19.

PNNL researchers established an Internet of Things Common Operating Environment (IoTCOE) laboratory to explore the risks associated with IoT connectivity to the internet, the energy grid and other critical infrastructures.

PNNL cancer cell biologist Karin Rodland has been recognized by the international Human Proteome Organization.

Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.

Pacific Northwest National Laboratory (PNNL) is part of a continuing National Science Foundation (NSF) team investigating the environmental impact of nanoparticles at the molecular level.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.

Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.

After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

PNNL scientists are on the front lines fighting against biological threats through early detection, diagnosis, and prevention strategies.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

PNNL scientists Richard (Dick) Smith and Ljiljana (Lili) Paša-Tolić are recognized by The Analytical Scientist in its 2019 Power List as two of 2019’s top 100 minds in analytical science.